Druggio Logo

Druggio

Teijin Pharma

Teijin Pharma is a Japanese pharmaceutical company that focuses on research, development, manufacturing, and marketing of pharmaceutical products. They develop drugs primarily in the areas of respiratory diseases, bone and joint diseases, and circulatory diseases. Founded in 1940, Teijin Pharma has a strong focus on improving patient outcomes through the development of innovative and effective treatments for various medical conditions. Some of their key therapeutic areas include asthma, chronic obstructive pulmonary disease (COPD), and osteoporosis.

Teijin Pharma's Drugs

Alvesco

Approval date

2007/4/18

Treats

Feburic

Approval date

2011/1/21

Treats

Revcovi

Approval date

2019/3/26

Xeomin

Approval date

2020/6/29

オスタバロ

Approval date

2021/3/23

Treats